Midwife Licensure Exam Reproductive Anatomy & Physiology — Reproductive Anatomy, Physiology & the Menstrual CycleSummary

The male reproductive system consists of the testes (paired gonads within the scrotum), accessory ducts (epididymis, vas deferens), accessory glands (seminal vesicles, prostate, bulbourethral glands), and the penis. The scrotum maintains the testes at approximately 1–2°C below core body temperature, which is essential for normal spermatogenesis. The epididymis is where sperm mature and gain motility. The seminal vesicles contribute fructose-rich alkaline fluid; the prostate adds a thin alkaline secretion that neutralizes vaginal acidity; and the bulbourethral glands provide pre-ejaculate lubrication. Together, these structures produce, mature, store, and deliver approximately 2–5 mL of semen containing ≥15 million sperm/mL (WHO reference standard) per ejaculation.

Spermatogenesis is the continuous process of sperm production that begins at puberty and continues throughout adult life. The process requires approximately 64–74 days from initiation in the seminiferous tubules to mature, motile sperm. Follicle-stimulating hormone (FSH) acts on Sertoli cells to support sperm development, while testosterone, secreted by Leydig (interstitial) cells in response to luteinizing hormone (LH), provides the androgenic environment necessary for spermatogenesis. Each mature sperm carries either an X chromosome or a Y chromosome; therefore, the father's sperm determines the genetic sex of the offspring. A normal ejaculate contains approximately 2–5 mL of fluid with a minimum concentration of 15 million sperm/mL, although higher counts are associated with increased fertility.

The female external genitalia, collectively called the vulva, include the mons pubis (fatty cushion over the symphysis pubis), labia majora (larger outer folds), labia minora (smaller inner folds), clitoris (erectile sensory organ), vestibule (space between labia minora), urethral opening, vaginal opening, Bartholin's glands (lubrication), and perineum (the area between the vaginal opening and anus). The perineum is clinically significant because it is the site of episiotomy (surgical incision to enlarge the vaginal opening) or spontaneous laceration during childbirth. Proper nursing assessment of perineal integrity postpartum is essential to detect infection or inadequate healing, and patient teaching on perineal hygiene (front-to-back wiping) protects the naturally acidic vaginal environment.

The vagina is a muscular, distensible canal that serves as the birth canal, passage for menstrual flow, and organ of coitus. It maintains an acidic pH of approximately 3.5–4.5 due to Döderlein's lactobacilli (normal flora), which provides natural protection against ascending infection. The uterus is a pear-shaped muscular organ with three regions: the fundus (top, palpated to assess pregnancy size and postpartum involution), the body/corpus (middle), and the cervix (lower neck opening into the vagina). The uterine wall consists of three layers: the perimetrium (outer serosa), the myometrium (thick muscular layer that contracts during labor and compresses bleeding vessels after birth), and the endometrium (inner mucosal lining shed during menstruation and site of implantation). The uterus is normally positioned anteverted (tilted forward) and anteflexed (bent forward). The fallopian (uterine) tubes, approximately 10 cm long, extend laterally from the uterus toward the ovaries; the fimbriae (finger-like projections) sweep the ovum into the tube, and fertilization typically occurs in the ampulla (outer third). Cilia and peristalsis transport the ovum toward the uterus. The ovaries are paired gonads that contain oocytes, release a mature ovum approximately once per menstrual cycle (ovulation), and secrete estrogen and progesterone. A female is born with approximately 1–2 million oocytes, which decline to about 400,000 at puberty; of these, approximately 400 oocytes will ovulate during her reproductive years.

The bony pelvis forms the birth canal and is clinically assessed during pregnancy to determine pelvic adequacy for vaginal delivery. The true (lesser) pelvis is the obstetric pelvis through which the fetus must pass. The most favorable pelvic shape for vaginal birth is the gynecoid pelvis, characterized by a rounded pelvic inlet, straight side walls, and a well-rounded subpubic angle. Clinical assessment includes measurement of the diagonal conjugate (approximately 12.5 cm), the distance from the lower border of the symphysis pubis to the sacral promontory, which can be measured vaginally during examination. The true (obstetric) conjugate, measuring approximately 11 cm or more, is the shortest anterior-posterior diameter of the pelvic inlet and cannot be directly measured but is estimated by subtracting 1.5–2 cm from the diagonal conjugate. A pelvic inlet contracted below 10 cm or an outlet contracted below 8 cm predisposes to cephalopelvic disproportion (fetal head too large to pass through pelvis), necessitating cesarean delivery.

Reproductive hormones form a tightly integrated hypothalamic-pituitary-gonadal axis that regulates the menstrual cycle and fertility. Gonadotropin-releasing hormone (GnRH), secreted by the hypothalamus, stimulates the anterior pituitary to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH). FSH stimulates ovarian follicle growth in females and spermatogenesis in males via Sertoli cells. LH triggers ovulation (via a sharp surge at mid-cycle) and stimulates formation of the corpus luteum; in males, LH stimulates testosterone secretion by Leydig cells. Estrogen, primarily secreted by the developing ovarian follicle, promotes endometrial proliferation, develops secondary female sex characteristics, and produces thin, clear, stretchy cervical mucus (spinnbarkeit) conducive to sperm transport. Rising estrogen levels trigger positive feedback that initiates the LH surge, which is the hormonal trigger for ovulation. Progesterone, secreted by the corpus luteum (and later by the placenta during pregnancy), transforms the endometrium from proliferative to secretory, thickens cervical mucus (making it hostile to sperm), raises basal body temperature by approximately 0.3–0.5°C after ovulation, and relaxes smooth muscle to maintain pregnancy. Human chorionic gonadotropin (hCG), produced by the trophoblast/placenta after implantation, maintains the corpus luteum and prevents its regression, ensuring continued progesterone secretion to sustain early pregnancy. hCG is the hormone detected by pregnancy tests.

The menstrual cycle is a monthly sequence of physiological changes that prepare the female body for pregnancy. The average cycle length is 28 days, with a normal range of 21–35 days; menstrual flow lasts 2–7 days with average blood loss of 30–80 mL. Cycle day 1 is defined as the first day of menstrual bleeding. The ovarian cycle comprises three phases: (1) The follicular phase (days 1–13, variable length) begins on day 1 of menses and is driven by rising FSH levels, which stimulate growth of multiple ovarian follicles. One follicle becomes the dominant (Graafian) follicle, producing increasing amounts of estrogen while others regress. The follicular phase ends with ovulation and varies in length, contributing to overall cycle-length variation. (2) Ovulation (approximately day 14 in a 28-day cycle) occurs when estrogen levels reach a threshold, triggering a sharp LH surge that ruptures the mature follicle and releases the ovum. Some women experience mittelschmerz (mid-cycle pelvic or lower abdominal pain) or mid-cycle spotting. (3) The luteal phase (days 15–28, fixed approximately 14 days) follows ovulation; the ruptured follicle transforms into the corpus luteum (yellow body), which secretes progesterone and some estrogen. If fertilization does not occur, the corpus luteum regresses to a fibrous corpus albicans after 10–12 days; falling progesterone and estrogen trigger endometrial shedding and menstruation. The luteal phase is remarkably constant at approximately 14 days; therefore, cycle-length variation results from variation in the follicular phase. For cycles longer or shorter than 28 days, ovulation can be estimated as cycle length minus 14 days (not always day 14).

The endometrial cycle describes changes in the uterine lining that parallel the ovarian cycle and prepare the endometrium for implantation. The menstrual phase (days 1–5) occurs when progesterone and estrogen levels drop sharply following corpus luteum regression; the functional endometrium (zona functionalis) sheds as menstrual flow, lasting 2–7 days. The proliferative phase (days 6–14, coinciding with the ovarian follicular phase) is dominated by rising estrogen from the developing follicle; estrogen stimulates endometrial epithelial cell proliferation and glandular development, rebuilding and thickening the endometrium in preparation for implantation. The proliferative phase ends at ovulation. The secretory phase (days 15–28, coinciding with the ovarian luteal phase) is dominated by progesterone from the corpus luteum; progesterone converts the endometrium into a nutrient-rich, highly glandular lining with increased vascularity and mucus secretion—an ideal environment for implantation. If pregnancy does not occur, falling progesterone triggers endometrial degeneration and the onset of menstruation, restarting the cycle.

Several physical signs and symptoms coincide with ovulation and are used in fertility awareness-based methods (FAM) for either planning or avoiding pregnancy. Basal body temperature (BBT)—the body's lowest temperature, measured immediately upon waking before any activity—dips slightly in the 24 hours before ovulation and then rises approximately 0.3–0.5°C after ovulation due to progesterone's thermogenic effect. This elevated temperature persists until menstruation. Cervical mucus undergoes characteristic changes: during the follicular phase, under increasing estrogen, mucus becomes clear, thin, slippery, and stretchy—described as having spinnbarkeit (the ability to stretch in a string between fingers without breaking), resembling 'raw egg white'—and is conducive to sperm transport. After ovulation, progesterone causes the mucus to become thick, cellular, and white or yellowish, creating a hostile environment to sperm. The cervix itself softens, opens slightly, and rises higher in the vagina around ovulation; these changes are detectable by trained patients or healthcare providers. Some women experience mittelschmerz, a sharp or cramp-like pelvic or lower abdominal pain lasting minutes to hours around ovulation, thought to result from follicle rupture or peritoneal irritation. Mid-cycle spotting (light vaginal bleeding) may accompany ovulation, resulting from the hormonal shift.

The fertile window is the period during which unprotected intercourse may result in pregnancy, determined by the survival times of the ovum and sperm. The ovum survives approximately 24 hours after ovulation; sperm survive approximately 48–72 hours in the acidic vaginal environment, but can survive up to 5 days in the alkaline fertile cervical mucus of the periovulatory period. Therefore, the fertile window extends approximately 5 days before ovulation through 1 day after ovulation (a 6-day window in a typical cycle). Fertilization occurs when one sperm penetrates the ovum, typically in the ampulla (outer third) of the fallopian tube. The fertilized cell is called a zygote and contains 46 chromosomes (23 from each parent). The zygote undergoes rapid cell division (cleavage) as it is transported along the fallopian tube by peristalsis and ciliary action, first becoming a morula (solid ball of cells), then a blastocyst (fluid-filled hollow sphere with an inner cell mass). The blastocyst reaches the uterine cavity approximately 3–4 days after fertilization and floats freely for 2–3 days before implanting into the endometrium, approximately 6–10 days after fertilization. This timing coincides with the secretory phase of the endometrial cycle, when the endometrium is maximally receptive to implantation (the 'window of implantation').

Fecundity is the biological capacity to achieve pregnancy in a given menstrual cycle; it declines with female age, particularly after approximately 35 years. This decline reflects both a decrease in the absolute number of remaining oocytes and a decline in oocyte quality; genetic abnormalities in oocytes increase with maternal age, explaining the higher risk of chromosomal abnormalities (such as Down syndrome) in pregnancies of women over 35. The fertility implications of age are crucial in counseling; infertility is defined as failure to achieve pregnancy after 12 months of regular unprotected intercourse (or 6 months if the woman is over 35). Menopause is the permanent cessation of menstruation, defined retrospectively as 12 consecutive months without menstrual bleeding; the average age is approximately 51 years. The perimenopause (or climacteric), the years of transition leading to menopause, is marked by irregular menstrual cycles, declining estrogen levels, and vasomotor symptoms such as hot flushes, night sweats, and mood changes. Menopause marks the end of natural fertility, though hormone replacement therapy may be considered for symptom management in some women. During the fertile years, nurses counsel patients that fertility planning should account for age-related changes.

Nurses must recognize terminology for abnormal menstrual patterns so they can accurately assess, document, and educate patients on when to seek medical evaluation. Amenorrhoea is the absence of menstruation; primary amenorrhoea occurs when menses have never begun (usually investigated if absent by approximately age 15–16), while secondary amenorrhoea occurs when menses cease after having occurred (pregnancy is the most common cause). Dysmenorrhoea is menstrual pain; primary dysmenorrhoea occurs without underlying pathology and results from elevated prostaglandins causing uterine contractions, while secondary dysmenorrhoea is painful menses caused by pathology such as endometriosis or fibroids and typically worsens over time. Menorrhagia refers to abnormally heavy or prolonged menstrual bleeding (excessive volume or duration); metrorrhagia refers to bleeding between menstrual periods (intermenstrual bleeding). Oligomenorrhoea describes infrequent, light menstruation (cycles >35 days or scant flow), while polymenorrhagia or polymenorrhoea describes abnormally frequent periods (cycles <21 days). Postmenopausal bleeding (any bleeding >12 months after the final menstrual period) is abnormal and always warrants investigation. These distinctions guide nursing assessment and patient education; any significant change in menstrual pattern, heavy bleeding, or postmenopausal bleeding warrants medical referral and investigation.

Infertility is defined as failure to conceive after 12 months of regular unprotected intercourse in couples where the woman is under 35 years, or after 6 months in couples where the woman is 35 years or older (reflecting the accelerated decline in fecundity with advancing maternal age). Infertility affects approximately 1 in 7–8 couples and may be attributed to female factors (approximately one-third of cases; includes anovulation, tubal obstruction or dysfunction, endometriosis, poor oocyte quality), male factors (approximately one-third; includes low sperm count, poor motility, abnormal morphology), combined factors, or remain unexplained (approximately one-third). The nursing role in infertility care includes detailed reproductive history taking (cycle length, regularity, dysmenorrhoea, prior pelvic infections), fertility awareness teaching, timing intercourse appropriately around ovulation, psychological support, and coordination with reproductive specialists when needed. Nurses provide anticipatory guidance and emotional support, as infertility is associated with psychological distress, relationship strain, and needs for grieving and acceptance.